PCOS Is Now PMOS: Why the Name Changed and What It Means for Your Health

If you’ve recently seen the term PMOS instead of PCOS, you might be wondering if they’re talking about a completely different condition. Did your diagnosis change? Are there new treatment recommendations? Or is this simply another medical acronym to learn?

The good news is that your diagnosis has not changed. What has changed is the name. After decades of research and advocacy from healthcare professionals and people living with the condition, experts have agreed that the term Polycystic Ovary Syndrome (PCOS) no longer reflects what this condition truly looks like. The new name, Polyendocrine Metabolic Ovarian Syndrome (PMOS), paints a much more accurate picture of what many people experience.

Table of Contents

PCOS is now PMOS: Why the old name never told the whole story

For years, many people living with PCOS have said the name never quite fit.
Some were diagnosed despite never having ovarian cysts. Others found that their biggest struggles weren’t irregular periods or fertility challenges. Instead, they were dealing with insulin resistance, elevated cholesterol, fatigue, or blood sugar concerns.

Yet the name focused almost entirely on the ovaries.

Researchers felt the same way.

In 2026, an international group of researchers, healthcare professionals, and patient organizations reached a global consensus to rename the condition Polyendocrine Metabolic Ovarian Syndrome (PMOS). The decision wasn’t made overnight. More than 14,000 people living with PCOS and healthcare professionals from around the world participated in surveys and consensus building to choose a name that better reflects current science. Their goal was to better describe the condition that has always existed.

The researchers also noted that the old name contributed to confusion, stigma, delayed diagnosis, and fragmented care because it overlooked the hormonal and metabolic features that affect so many people living with the condition.

A quick refresher on PCOS

Before we dive into PMOS, let’s quickly review what PCOS actually is.

PCOS is one of the most common hormonal conditions, affecting about 1 in 8 women of reproductive age. It can affect much more than menstrual cycles and fertility.

Common symptoms include:

• Irregular or absent menstrual periods
• Acne
• Increased facial or body hair growth
• Hair thinning
• Difficulty becoming pregnant
• Weight changes
• Insulin resistance
• Elevated cholesterol

Many people are surprised to learn that ovarian cysts are not required for a PCOS diagnosis.

Healthcare providers typically diagnose PCOS using the Rotterdam Criteria, which looks for two out of three features:

• Irregular or absent ovulation
• Signs of elevated androgens (male hormones), either through symptoms or lab work
• Polycystic appearing ovaries on ultrasound

That means someone can have PCOS without ever having ovarian cysts.

Beyond PCOS: What does PMOS stand for?

The new name, Polyendocrine Metabolic Ovarian Syndrome, better reflects the many body systems involved.

Polyendocrine

“Polyendocrine” recognizes that PMOS affects multiple hormone systems, not only reproductive hormones. People living with PMOS may experience changes in insulin, testosterone, estrogen, luteinizing hormone, and other hormones that work together to regulate metabolism, reproduction, and overall health.

Metabolic

This is perhaps the biggest reason the name changed. In my experience as a dietitian, many clients come to us because they’re struggling with insulin resistance, elevated blood sugar, high cholesterol, or unexplained fatigue long before they’re thinking about fertility.

Research has consistently shown that people with PMOS have an increased risk of insulin resistance, prediabetes, type 2 diabetes, and cardiovascular disease. In fact, the 2023 International Evidence Based PCOS Guideline now recommends greater awareness of cardiovascular risk and comprehensive metabolic screening as part of routine care.

Adding the word “metabolic” recognizes something researchers have known for years. PMOS affects much more than the reproductive system.

Ovarian

The ovaries are still an important part of the condition. Many people continue to experience irregular ovulation and ovarian changes, which is why “ovarian” remains part of the name.

The difference is that the ovaries are no longer the entire story.

The name changed. Your diagnosis didn’t.

One of the biggest questions we’ve been hearing is whether PMOS changes how the condition is diagnosed.

For now, the answer is no.

Healthcare providers will continue using the same diagnostic criteria while the medical community transitions to the new terminology. If you’ve already been diagnosed with PCOS, your diagnosis remains valid.

What may change over time is the conversation surrounding your care.

• Instead of focusing only on menstrual cycles or fertility, providers may place greater emphasis on monitoring:
• Blood sugar
• Cholesterol
• Blood pressure
• Cardiovascular health
• Long term metabolic health

I actually see this as a positive shift. Looking at the whole picture creates more opportunities for early intervention and personalized care.

Nutrition recommendations aren’t changing. The conversation is.

You may be wondering whether the new name comes with a completely different nutrition plan.

Not really.

Nutrition has always played an important role in managing PCOS, especially for people living with insulin resistance. The difference is that the word “metabolic” helps highlight why nutrition is such an important part of care.

At Diabetes Digital, we don’t believe in eliminating entire food groups or chasing the latest restrictive diet. Instead, we help clients build eating patterns that support steady blood sugar, balanced energy, hormone health, and overall well being.

That may include:

• Eating enough protein throughout the day
• Including fiber rich carbohydrates
• Pairing carbohydrates with protein or healthy fats
• Finding movement that feels realistic
• Supporting sleep and stress management
• Creating habits that fit your culture, preferences, and lifestyle
• Every person with PMOS is different, which is exactly why nutrition recommendations should be individualized.

Why working with a dietitian can make a difference

One of the hardest parts of living with PMOS is sorting through all the conflicting advice online: One person tells you to cut out carbohydrates. Another says you need to avoid dairy forever. Someone else insists supplements will fix everything. It can feel overwhelming.

Working with a registered dietitian gives you the opportunity to create a plan based on your unique symptoms, lab values, medical history, and goals.

In my experience, many clients feel relieved when they realize they don’t have to give up the foods they love to support their health.

Instead, we work together to understand how your body responds to different foods, improve blood sugar patterns, support hormone health, and build habits that feel sustainable for the long term.

PCOS to PMOS: Why this name matters

Changing the name from PCOS to PMOS isn’t simply changing an acronym.

For many people, it validates experiences they’ve had for years. Maybe you’ve wondered why you were diagnosed with a condition called “polycystic ovary syndrome” even though you’ve never had ovarian cysts. Maybe your biggest concern has always been insulin resistance instead of irregular periods. Maybe no one ever talked to you about your cholesterol, blood pressure, or future diabetes risk.

The PCOS to PMOS name change encourages a broader understanding of the condition and reminds both patients and healthcare providers that comprehensive care should extend beyond reproductive health alone.

Whether your medical record says PCOS or PMOS, you deserve care that recognizes the full picture.

Frequently Asked Questions

Clinical Sources

Teede HJ, Bahri Khomami M, Morman R, et al. Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: a multistep global consensus process. The Lancet. 2026.
Tay CT, Mousa A, Vyas A, et al. 2023 International Evidence Based Polycystic Ovary Syndrome Guideline Update: Insights From a Systematic Review and Meta Analysis on Elevated Clinical Cardiovascular Disease in Polycystic Ovary Syndrome. Journal of the American Heart Association. 2024.